TABLE 2.
Variables | Anxiety n (%) | p‐Value | Depression n (%) | p‐Value | ||
---|---|---|---|---|---|---|
No | Yes | No | Yes | |||
Total, n | 335 (73.8) | 119 (26.2) | 317 (69.8) | 137 (30.2) | ||
Age, a years | 57.5 (11.3) | 55.2 (11.4) | 0.059 | 57.2 (11.4) | 56.2 (11.3) | 0.420 |
Gender | ||||||
Female | 138 (41.2) | 52 (43.7) | 0.634 | 133 (42.0) | 57 (41.6) | |
Male | 197 (58.8) | 67 (56.3) | 184 (58.0) | 80 (58.4) | ||
Marital status | ||||||
Married | 321 (95.8) | 113 (95.0) | 0.694 | 306 (96.5) | 128 (93.4) | 0.140 |
Single b | 14 (4.2) | 6 (5.0) | 11 (3.5) | 9 (6.6) | ||
Education | ||||||
≤9 years | 170 (50.7) | 57 (47.9) | 0.594 | 157 (49.5) | 70 (51.1) | 0.759 |
≥10 years | 165 (49.3) | 62 (52.1) | 160 (50.5) | 67 (48.9) | ||
ECOG PS c | ||||||
0 and 1 | 277 (82.7) | 91 (76.5) | 0.137 | 264 (83.3) | 104 (75.9) | 0.066 |
2 | 58 (17.3) | 28 (23.5) | 53 (16.7) | 33 (24.1) | ||
Disease stage | ||||||
No evidence of disease | 13 (3.9) | 7 (5.9) | <0.001 | 13 (4.1) | 7 (5.1) | <0.001 |
Locoregional | 108 (32.2) | 72 (60.5) | 102 (32.2) | 78 (56.9) | ||
Locoregional plus metastatic | 7 (2.1) | 4 (3.4) | 8 (2.5) | 3 (2.2) | ||
Metastatic | 207 (61.8) | 36 (30.3) | 194 (61.2) | 49 (35.8) | ||
Disease status | ||||||
Complete remission | 6 (1.8) | 10 (8.4) | <0.001 | 5 (1.6) | 11 (8.0) | <0.001 |
Partial remission | 60 (17.9) | 44 (37.0) | 57 (18.0) | 47 (34.3) | ||
Stable disease | 165 (49.3) | 36 (30.3) | 162 (51.1) | 39 (28.5) | ||
Progressive disease | 71 (21.2) | 22 (18.5) | 62 (19.6) | 31 (22.6) | ||
Unclear | 33 (9.9) | 7 (5.9) | 31 (9.8) | 9 (6.6) | ||
Current cancer therapy | ||||||
Palliative care | 121 (36.1) | 62 (52.1) | 0.002 | 105 (33.1) | 78 (56.9) | <0.001 |
Anticancer therapy | 214 (63.9) | 57 (47.9) | 212 (66.9) | 59 (43.1) | ||
Symptom burden a | 18.29 (16.32) | 43.20 (22.10) | <0.001 | 17.85 (16.55) | 40.95 (21.61) | <0.001 |
Note: Significance level at p < 0.05.
Using mean (SD).
Including divorced or windowed.
For Eastern Cooperative Oncology Group performance status.